Find information on thousands of medical conditions and prescription drugs.

Bowen's disease

In medicine (dermatology), Bowen's disease (BD) is a sunlight-induced skin disease, considered either as an early stage or intraepidermal form of squamous cell carcinoma. It was named after Dr John T. Bowen, the doctor who first described it in 1912. more...

Home
Diseases
A
B
Babesiosis
Bacterial endocarditis
Bacterial food poisoning
Bacterial meningitis
Bacterial pneumonia
Balantidiasis
Bangstad syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Barrett syndrome
Barth syndrome
Basal cell carcinoma
Bathophobia
Batrachophobia
Batten disease
Becker's muscular dystrophy
Becker's nevus
Behcet syndrome
Behr syndrome
Bejel
Bell's palsy
Benign congenital hypotonia
Benign essential tremor...
Benign fasciculation...
Benign paroxysmal...
Berdon syndrome
Berger disease
Beriberi
Berylliosis
Besnier-Boeck-Schaumann...
Bibliophobia
Bicuspid aortic valve
Biliary atresia
Binswanger's disease
Biotinidase deficiency
Bipolar disorder
Birt-Hogg-Dube syndrome
Blastoma
Blastomycosis
Blepharitis
Blepharospasm
Bloom syndrome
Blue diaper syndrome
Blue rubber bleb nevus
Body dysmorphic disorder
Boil
Borreliosis
Botulism
Bourneville's disease
Bowen's disease
Brachydactyly
Brachydactyly type a1
Bradykinesia
Bright's disease
Brittle bone disease
Bromidrosiphobia
Bronchiectasis
Bronchiolotis obliterans...
Bronchopulmonary dysplasia
Brown-Sequard syndrome
Brucellosis
Brugada syndrome
Bubonic plague
Budd-Chiari syndrome
Buerger's disease
Bulimia nervosa
Bullous pemphigoid
Burkitt's lymphoma
Byssinosis
Cavernous angioma
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Causes

Causes of BD include solar damage, arsenic, immunosuppression (including AIDS), viral infection (human papillomavirus or HPV) and chronic skin injury and dermatoses.

Signs and symptoms

Bowen's disease typically presents as a gradually enlarging, well demarcated erythematous plaque with an irregular border and surface crusting or scaling. BD may occur at any age in adults but is rare before the age of 30 years - most patients are aged over 60. Any site may be affected, although involvement of palms or soles is uncommon. BD occurs predominantly in women (70-85% of cases); about three-quarters of patients have lesions on the lower leg (60-85%), usually in previously or presently sun-exposed areas of skin.

Histology

The cells in Bowen's are extremely unusual or atypical under the microscope and in many cases look worse under the microscope than the cells of many outright and invading squamous-cell carcinomas. The degree of atypia (strangeness, unusualness) seen under the microscope best tells how cells may behave should they invade another portion of the body.

Treatment

Cryotherapy (freezing) or local chemotherapy (with 5-fluorouracil) are favored by some clinicians over excision.

Read more at Wikipedia.org


[List your site here Free!]


Red light laser photodynamic therapy of Bowen's disease
From Journal of Drugs in Dermatology, 11/1/04 by Eric C. Parlette

Case Report

A 68-year-old white male presented with a history of a slowly enlarging erythematous plaque on his left posterior upper arm over the past 7 years. On physical examination, the patient had a 4-cm erythematous, finely scaling, well-demarcated plaque on his left posterior, mid upper arm (Figure 1). Biopsy of the lesion confirmed a diagnosis of Bowen's disease (Figure 2). Given the extensive size of the lesion and location, we opted to treat the patient with photodynamic therapy with topical aminolevulinic acid.

[ILLUSTRATION OMITTED]

Day one, the patient presented for application of the aminolevulinic acid hydrochloride 20% (ALA) solution at 2:35 pm. The entirety of the contents from a Levulan[R] Kerastick[R] (ALA), 350 mg, was topically applied to the plaque of Bowen's disease on the patient's left posterior upper arm. The plaque was then occluded with a completely opaque dressing (Figure 3). He was instructed to keep this area dry and out of the sun until follow-up the next day at 8 am.

[FIGURE 1 OMITTED]

[FIGURE 2 OMITTED]

Day two, the patient returned for follow-up and photodynamic therapy (PDT) using a 630-nm dye laser. A prescribed light dose of 150 Joules/[cm.sup.2] was calculated. The PDT calibrated output power was 2.98 Watts. The treatment area was 12.57[cm.sup.2]. Dose rate being equal to output power/treatment area was 0.237W/[cm.sup.2]. The treatment time, light dose/dose rate, was determined to be 632 seconds (10.5 minutes).

[FIGURE 3 OMITTED]

[FIGURE 4 OMITTED]

[FIGURE 5 OMITTED]

[FIGURE 6 OMITTED]

[FIGURE 7 OMITTED]

[FIGURE 8 OMITTED]

[FIGURE 9 OMITTED]

The ALA was left in place for a total of 18 hours, 25 minutes before treatment. The area was locally anesthetized using 9cc of 2% lidocaine with epinephrine. A 630-nm dye laser was then used to activate the protoporphyrin IX. The perpendicular treatment distance was 7.0 cm with a treatment area of 12.57[cm.sup.2] and field diameter of 4.0 cm (Figure 4). The patient remained motionless during the course of the procedure with out any discomfort. The patient noted significant aching in the treatment zone over the next 18 hours which was relieved with oral narcotics. This quickly resolved and was subsequently asymptomatic for the remainder of the healing process.

At 2 weeks follow-up, the treated plaque was erythematous and still appeared to be significantly inflamed (Figure 5). One week later, at 3 weeks, the erythema and inflammation had substantially subsided (Figure 6). At 1 month, there was very trace erythema in the treatment zone with focal alopecia of the entire area (Figure 7). At two and a half months follow-up, there was no clinical evidence of tumor, only persistent alopecia (Figure 8). The patient remains disease free at over 2 years follow-up (Figure 9). There is still complete alopecia involving the entire 4-mm treatment area. The alopecia supports the fact that topical ALA photodynamic therapy with 630-nm dye laser effectively treats down to the level of the follicular epithelial atypia seen in Bowen's disease.

ERIC C. PARLETTE MD LCDR MC USNR

DERMATOLOGY DEPARTMENT, NAVAL MEDICAL CENTER, SAN DIEGO, CA

ADDRESS FOR CORRESPONDENCE:

Eric C. Parlette MD LCDR MC USNR

Dermatology Department

Naval Medical Center, San Diego

34520 Bob Wilson Drive, Suite 300

San Diego, CA 92134-2300

e-mail: ecparlette@yahoo.com

COPYRIGHT 2004 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2005 Gale Group

Return to Bowen's disease
Home Contact Resources Exchange Links ebay